The effect of empagliflozin and sitagliptin as an add-on therapy to metformin in blood pressure reduction in diabetic patients in primary health care settings in Riyadh, Saudi Arabia
Although neither drug significantly impacted BP, both combinations reduced HbA1c. Further research with a larger sample is needed to clarify their effects on BP.
Authors
- Mayada Ahmed
- Reema Aldhalaan
- Mohammed Altoyan
- Joud A Aljebreen
- Raghad Hijazi
- Mohammed H. Alshalan (ORCID: https://orcid.org/0009-0005-7494-2011)
- Lama Altarifi
Institutions
- Alfaisal University (SA)
- King Faisal Specialist Hospital & Research Centre (SA)
- Sulaiman Al Rajhi Colleges (SA)
- National Guard Health Affairs (SA)
Publication Details
- Journal
- Journal of Family Medicine and Primary Care
- Published
- 2025-03-01
- DOI
- https://doi.org/10.4103/jfmpc.jfmpc_1529_24
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00